Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Non Operating Income: 2013-2025

Historic Other Non Operating Income for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to $231,000.

  • Amphastar Pharmaceuticals' Other Non Operating Income rose 104.53% to $231,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 156.44%. This contributed to the annual value of $4.1 million for FY2024, which is 203.74% up from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Other Non Operating Income stood at $231,000, which was down 84.71% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Other Non Operating Income ranged from a high of $13.3 million in Q3 2021 and a low of -$5.5 million during Q4 2023.
  • In the last 3 years, Amphastar Pharmaceuticals' Other Non Operating Income had a median value of $231,000 in 2025 and averaged -$31,364.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Other Non Operating Income tumbled by 262.38% in 2023, and later surged by 1,618.21% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Other Non Operating Income (Quarterly) stood at $2.9 million in 2021, then grew by 15.58% to $3.4 million in 2022, then plummeted by 262.38% to -$5.5 million in 2023, then surged by 153.83% to $3.0 million in 2024, then spiked by 104.53% to $231,000 in 2025.
  • Its Other Non Operating Income stands at $231,000 for Q3 2025, versus $1.5 million for Q2 2025 and -$2.2 million for Q1 2025.